DTx: how to succeed in a fragmented regulatory landscape
This is part of a series dedicated to Digital Therapeutics, by Jovan Stevovic, CEO and founder chino.io Evolving and fragmented regulatory framewor…
This is part of a series dedicated to Digital Therapeutics, by Jovan Stevovic, CEO and founder chino.io Evolving and fragmented regulatory framewor…
This is part of a series dedicated to Digital Therapeutics, by Jovan Stevovic, CEO and founder chino.io No specific legal regulation exists on DTx …
This is part of a series dedicated to Digital Therapeutics, by Jovan Stevovic, CEO and founder chino.io An overview of the main reimbursement frame…
Akili, Inc. common stock to begin trading on Nasdaq under the ticker symbol “AKLI” on August 22, 2022 Total gross proceeds of more than $163 …
On the occasion of the seventh edition of our global conference, we at Frontiers Health have identified compelling guiding themes around whi…
In line with Frontiers theme of transformation, we will hold our FH22 in the Palazzo del Ghiaccio in Milan. Dating back to 1899 with origins…
Modern medical communications for the contemporary clinician PRESS RELEASE | London, UK and Salerno, Italy | 27 July 2022 – Healthware Group …
We are excited to announce that applications are now open to Frontiers Health's iconic Start-up Discovery session. Over our past…
We couldn’t be happier that all members of our outstanding Steering Committee will return at this year’s Frontiers Health Conference. …
Article originally posted on Healthwaregroup.com by Koushik Venkatanathan, Account Executive at Healthware International Recently Germany has made …